Hepatocyte nuclear factor 4␣ (HNF4␣) is an orphan receptor of the nuclear receptor superfamily and expressed in vertebrates as a tissue-specific transcription factor in liver, kidney, intestine, stomach, and pancreas. It also plays a crucial role in early embryonic development and has been identified as a maternal component in the Xenopus egg. We now report on an activity present in Xenopus embryos that inhibits the DNA binding of HNF4. This HNF4 inhibitor copurifies with a 25-kDa protein under nondenaturing conditions but can be separated from this protein by sodium dodecyl sulfate treatment. Protease treatment of the inhibitor results in a core fragment of about 5 kDa that retains full inhibitory activity. The activity of the HNF4 inhibitor can also be monitored in the absence of DNA, as it alters the mobility of the HNF4 protein in native polyacrylamide gels and the accessibility of antibodies. Comparing the activity of the HNF4 inhibitor with acyl coenzyme A's, recently proposed to be ligands of HNF4, we observe a more stringent specificity for the HNF4 inhibitor activity. Using deletion constructs of the HNF4 protein, we could show that the potential ligandbinding domain of HNF4 is not required, and thus the HNF4 inhibitor does not represent a classical ligand as defined for the nuclear receptor superfamily. Based on our previous finding that maternal HNF4 is abundantly present in Xenopus embryos but the target gene HNF1␣ is only marginally expressed, we propose that the HNF4 inhibitor functions in the embryo to restrict the activity of the maternal HNF4 proteins.Hepatocyte nuclear factor 4 (HNF4) constitutes transcription factor subfamily 2A (28), whose first member, HNF4␣ (NR2A1), has been identified as a factor interacting with promoter elements mediating liver-specific transcription (35). Based on the zinc finger motif of the DNA-binding domain and on a potential ligand-binding domain, HNF4 is classified as a member of the nuclear orphan receptor superfamily (33). Recently, it has been reported that acyl coenzyme A's (acylCoAs) are potential ligands of HNF4␣: acyl-CoAs containing fatty acids with 16 C residues or shorter act as agonists by increasing the DNA-binding potential of HNF4␣, whereas acyl-CoAs with 18 C residues or longer have antagonistic properties and inhibit DNA binding of HNF4␣ (11). HNF4␣ turned out to be present as well in nonhepatic cells such as kidney, intestine, stomach, and pancreas (23,38,45). The importance of HNF4␣ in gene control in tissues distinct from the liver has been documented by the fact that an inherited human disease is based on the expression of a mutated HNF4␣ gene in the  cells of the endocrine pancreas, leading to maturity-onset diabetes of the young (MODY1 [42]). Most interestingly, another MODY gene identified in humans represents the tissuespecific transcription factor HNF1␣ (43), known to be tightly regulated by HNF4 (17,39,44).In addition to its role as a tissue-specific transcription factor, HNF4␣ is also a maternal component in the egg of Drosophila melano...